tirzepatide in type 1 diabetes 📊 Another new retrospective cohort of published this week. 142 adults with T1D and obesity (mean BMI 37.4) started on tirzepatide vs 50 age, sex, and BMI Tirzepatide Shows Substantial Weight Loss

Rotating injection sites actually supports consistent effectiveness by preventing tissue adaptation at any single location

This is where GLP-1 medications come in, offering a powerful, science-backed approach

As GLP-1 receptor agonist [GLP1ra] medications become increasingly integrated into the care of patients undergoing body contouring, our findings suggest that these drugs may have subtle effects on wound healing, even if they dont increase overall surgical risks, says Zachary Andrew Koenig, MD, of West Virginia University School of Medicine, in a release

10.1038/s41574-020-0355-7 51 Diagnosis and Classification of Diabetes Mellitus (2013)